CLYM
Climb Bio, Inc. Common Stock
stockNASDAQ
At CloseOct 2, 2026 3:59:59 PM EDT
10.94USD-1.264%(-0.14)1,574,941
Pre-marketOct 5, 2026 8:36:30 AM EDT
10.90USD-0.366%(-0.04)
After-hoursOct 2, 2026 4:30:30 PM EDT
10.79USD-1.371%(-0.15)
Loading…
Loading…
627.77M
Previous Close
$11.07
Beta
1.80
52-Week High
$18.33 2026-08-25
52-Week Low
$1.54 2025-10-07
SMA 50
$14.07
SMA 200
$9.78
Avg. Vol 10D
1.36M
Avg. Vol 30D
1.65M
Avg. Vol 90D
1.45M
Relative Vol
0.95
57.44M
49.20M
85.66%
8,508,354
17.29%
4.53
59%/41%
59.07%
42.88%
0.4100%
700,000
279
5,420
27,387
Nov 5, 2026 (31d)
Oct 2, 2026
Climb Bio to present Phase 2 data on kidney disease therapies · 
Investing.com
Sep 23, 2026
The Biggest Losers In Biotech — And It Had Nothing To Do With 'Compelling,' 'Best-In-Disease' Data · 
Investor's Business Daily
Sep 17, 2026
CLYM Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 11.74 | 2026-09-28 | -6.90% | -0.240 |
| 1M | 15.52 | 2026-09-04 | -29.58% | -0.087 |
| 3M | 13.27 | 2026-07-06 | -17.64% | 0.540 |
| 6M | 6.74 | 2026-04-06 | +62.16% | 1.177 |
| 1Y | 1.81 | 2025-10-06 | +503.86% | 1.800 |
| 2Y | 5.16 | 2024-10-04 | +111.82% | — |
CLYM Stock Summary
Climb Bio, Inc. Common Stock (NASDAQ:CLYM) stock price today is $10.93, and today's volume is 1,575,012. CLYM is down 1.266% today. The 30 day average volume is 1.65M. CLYM market cap is $627.77M with 57.44M shares outstanding.